Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 23 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-23-2024-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 23, 2024, titled "Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases